Identification of a met-binding peptide from a phage display library

Area of Science:

• Oncology
• Molecular Biology
• Biotechnology

Background:

• Aberrant c-Met receptor tyrosine kinase expression is a hallmark of many human cancers.
• Targeting c-Met is a promising strategy for both cancer diagnostics and therapeutics.
• Developing specific agents to interact with c-Met is crucial for advancing cancer treatment.

Purpose of the Study:

• To identify and characterize novel peptides that specifically bind to the c-Met receptor.
• To evaluate the potential of a Met-binding peptide as a diagnostic imaging agent in vivo.
• To assess the therapeutic potential of the identified peptide in inhibiting tumor cell proliferation.

Main Methods:

• Biopanning using a random peptide phage display library against Met-expressing cell lines (S114, SK-LMS-1).
• In vitro characterization included competition ELISA, fluorescence-activated cell sorting, internalization, and cell proliferation assays.
• In vivo evaluation involved injecting 125I-labeled peptide into mice with Met-expressing xenografts and obtaining scintigrams.

Main Results:

• A specific Met-binding peptide, Met-pep1 (YLFSVHWPPLKA), was identified.
• Met-pep1 binds to cell surface Met, competes with HGF binding, and is internalized by Met-expressing cells.
• In vivo imaging demonstrated tumor-associated activity of radiolabeled Met-pep1 in xenografts within 1-24 hours postinjection.

Conclusions:

• Met-pep1 specifically interacts with the c-Met receptor.
• The peptide is internalized by target cells and inhibits tumor cell proliferation in vitro.
• Met-pep1 demonstrates potential as a diagnostic agent for tumor imaging.